Shadd Dales of The Dales Report asks InMed CEO, Eric A. Adams, about the growing interest in the pharmaceutical development of non-intoxicating cannabinoids.
Read the article and watch the full video at The Dales Report.
Peer-reviewed Publication: Rare phytocannabinoids exert anti-inflammatory effects on human keratinocytes via the endocannabinoid system and MAPK signalling pathway
A peer-reviewed scientific study entitled “Rare phytocannabinoids exert anti-inflammatory effects on human keratinocytes via the endocannabinoid system and MAPK signalling pathway” has been published in the International
March 13, 2023
